Egalet Ramps Up Commercial Ahead Of Abuse-Deterrent Pain Drug Filing
This article was originally published in The Pink Sheet Daily
Executive Summary
The specialty pharma has relaunched two drugs for pain – Sprix and Oxaydo – supported by a 50-person sales team, laying the groundwork to eventually bring to market an abuse-deterrent, extended-release morphine product.